May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Selective Laser Trabeculoplasty (SLT) as Primary Treatment for Open Angle Glaucoma. A Prospective, Non-Randomized Pilot Study
Author Affiliations & Notes
  • S. Melamed
    Glaucoma Unit Dept Ophthal, Goldschleger Eye Institute, Tel-Hashomer, Israel
  • G.J. Ben Simon
    Glaucoma Unit Dept Ophthal, Goldschleger Eye Institute, Tel-Hashomer, Israel
  • Footnotes
    Commercial Relationships  S. Melamed, None; G.J. Ben Simon, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Melamed, G.J. Ben Simon; Selective Laser Trabeculoplasty (SLT) as Primary Treatment for Open Angle Glaucoma. A Prospective, Non-Randomized Pilot Study . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To examine the safety and efficacy of Selective Laser Trabeculoplasty (SLT) as primary treatment for patients with Open Angle Glaucoma. Methods: Forty-five eyes of 31 patients with Open Angle Glaucoma (IOP≥23mmHg on two consecutive measurements) underwent selective laser trabeculoplasty as primary treatment. All patients underwent complete ophthalmic evaluation before and at certain intervals after treatment. This included visual acuity, slit-lamp examination, ophthalmoscopy, gonioscopy and visual field analysis. IOP measurements were obtained 1hr, 1day, 1 week, 1,3, 6 and 12 months postoperatively. During the follow-up period patients were treated with topical anti-glaucoma medications as required. Results: Mean IOP (±SD) has decreased by 8.1±3.6 mmHg (31.6%) from 25.6±2.5 mmHg to 17.6±3.2 mmHg (P=0.000). Only two eyes (4.4%) have not responded to SLT, and three eyes (6.7%) required topical medications to control their IOP at the end of the follow-up period. Forty cases (88.9%) had a decrease of 5 or more mmHg. Visual acuity, visual fields and gonioscopy remained unchanged. Complications included conjunctival redness and injection within one day post operatively in 30 eyes (66.7%). One hour after SLT, IOP rise above 5 mmHg was detected in five eyes (11.1%) while IOP rise between 2 and 5 mmHg was measured in three eyes (6.7%). Conclusions: Selective laser trabeculoplasty is effective and safe as a primary treatment for patients with OHT and Open Angle Glaucoma.

Keywords: laser • clinical research methodology • outflow: trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×